Loading clinical trials...
Loading clinical trials...
A Single-blind, Non-randomized Pharmacokinetic and Safety Study of Single Dose of GSK573719 and GSK573719 + GW642444 Combination in Healthy Subjects and in Subjects With Severe Renal Impairment
Conditions
Interventions
Inhaled GSK573719
Inhaled GSK573719/vilanterol
Locations
2
Czechia
GSK Investigational Site
Prague, Czechia
GSK Investigational Site
Budapest, Hungary
Start Date
March 29, 2012
Primary Completion Date
June 22, 2012
Completion Date
June 22, 2012
Last Updated
July 25, 2017
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions